Comparing amiodarone doses for paroxysmal AF
Part of Heart & circulation clinical trials.
This study compares three different daily doses of the heart rhythm medication amiodarone to find the most effective one for preventing episodes of paroxysmal atrial fibrillation. Participants will take one of three doses (100, 200, or 400 mg) for up to 12 months, and the study will monitor how well each dose controls the irregular heartbeat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- You need to have a confirmed diagnosis of paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes).
- Your doctor must consider amiodarone a good treatment option for you.
- You cannot have certain other heart conditions, such as severe coronary artery disease needing urgent treatment, or blood clots in the heart.
- You must not be taking specific other medications (like some antidepressants, antibiotics, or heart rhythm drugs).
- You cannot be pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine, budiodarone, to help control atrial fibrillation (an irregular heartbeat) in people who haven't been helped by other treatments. It may reduce the time spent in AF and improve symptoms.
This trial tests two different ways of taking amiodarone (a heart rhythm medicine) to keep your heart in a normal rhythm after a procedure called electrical cardioversion. It's designed for people with persistent atrial fibrillation (a fast, irregular heartbeat lasting at least 7 days).
This trial is testing whether giving amiodarone (a heart-rhythm medicine) before an electrical cardioversion can help restore normal heart rhythm better in people with persistent atrial fibrillation. The goal is to see if the medicine makes the procedure more likely to succeed and reduces the chance of the irregular rhythm returning.
This trial studies whether a short course of amiodarone started right after heart surgery can reduce problems from new-onset atrial fibrillation (a common fast heart rhythm) or flutter. It may help some patients avoid ongoing rhythm issues and improve recovery soon after discharge.
This study compares two ways of giving the heart-rhythm medication amiodarone—through an IV followed by pills, versus pills alone—after a standard catheter ablation procedure for people with persistent atrial fibrillation (long-lasting irregular heartbeat). The goal is to see which method better prevents AFib from coming back.
This study tests a stepwise treatment plan for people with persistent atrial fibrillation (a long-lasting irregular heartbeat) who also have an enlarged left atrium. It aims to see if a medication called amiodarone plus a cardioversion procedure can help restore normal rhythm.
Hear when a new Paroxysmal AF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.